Clinical Trials Browser

Phase 1/2 × Advanced Solid Tumours × 90 days × Clear all

NCT06795412 2026-03-06

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumours

NCT05508334 2025-12-22

A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumours